Explanipedia

Radiation-induced osteosarcoma of the frontoparietal calvaria 6 years after oligodendroglioma treatment: illustrative case. Open

Hakim S. Sultan Aljibori, Mohammadmahdi Sabahi, Shadi Bsat, Christopher W. Fleming, Scott E. Kilpatrick , et al. · 2025

Despite the lesion's rarity, suspicion for RIS should be raised with the rapid growth of a mass at the site of previous radiotherapy. Furthermore, it is especially important to carefully monitor vulnerable patients who may not be able to r…

A Reappraisal of Definitive Chemoradiotherapy for Older Adults With Advanced Head and Neck Cancer Open

Timothy D. Smile, C.A. Reddy, Brian Matia, Christopher W. Fleming, CHAIM DOMB , et al. · 2022

Patients aged ≥75 years received less aggressive therapy and experienced increased recurrence compared to younger patients. Outcomes for those aged 70-74 years were similar to younger patients treated with aggressive therapy, despite their…

Primary Total Laryngectomy versus Organ Preservation for Locally Advanced T3/T4a Laryngeal Cancer Open

Maxwell Lee, Mario Belfiglio, Johnathan Zeng, Christopher W. Fleming, Shlomo A. Koyfman , et al. · 2022

Objective Organ preservation (OP) treatment for advanced laryngeal cancer has increased compared to primary total laryngectomy. Our study compares oncologic and functional outcomes between these approaches. Study Design Retrospective cohor…

Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy for Head and Neck Cancer Open

Zachary Mayo, Evelyn O. Ilori, Brian Matia, Timothy D. Smile, Christopher W. Fleming , et al. · 2022

H-IMRT for the definitive or post-operative treatment of HNC using ≥50 Gy in 20 fractions appears safe and well tolerated with modest toxicity.

Head and Neck Stereotactic Body Radiation Therapy Re-Irradiation for Patients With Carotid or Skin Involvement Ineligible for RTOG 3507 Open

Shauna R. Campbell, Evelyn O. Ilori, Nikhil Joshi, N.M. Woody, H. Li , et al. · 2021

Updated Outcomes of Split Course Radiotherapy in Elderly or Infirm Patients With Advanced Cancers of the Head and Neck Open

Chaim Domb, Timothy D. Smile, C.A. Reddy, N.M. Woody, Shauna R. Campbell , et al. · 2021

SCRT offers an attractive treatment paradigm to personalize radiation intensity based on patient tolerance, while maintaining reasonable safety and efficacy in those unfit for standard full course RT.

Abstract No. 191 Adrenal venous sampling for lateralization of cortisol hypersecretion in patients with adrenocorticotropic hormone–independent Cushing syndrome and bilateral adrenal masses Open

Patrick W. Johnson, Scott M. Thompson, Daniel A. Adamo, Christopher W. Fleming, Irina Bancos , et al. · 2021

Prognostic Impact of Baseline and Delta Tumor Radiomics Features in Patients With Oropharyngeal Cancer (OPC) Treated With Adaptive Image-Guided Radiotherapy (IGRT) Open

Hesham Elhalawani, Christopher W. Fleming, Sanjay Rao, Y. Chen, Brian P. Hobbs , et al. · 2020

Adverse Radiologic Features associated with Worse Outcomes in cN2b-N3 (by AJCC 7th Ed) HPV- Head and Neck Cancers Open

Ian W. Winter, Sarah J. Stock, C.A. Reddy, Christopher W. Fleming, Nikhil Joshi , et al. · 2020

Management of Oligometastatic Prostate Cancer Open

James R. Broughman, Christopher W. Fleming, Omar Y. Mian, Kevin L. Stephans, Rahul D. Tendulkar · 2020

Pre-Treatment Factors Predictive of Distant Recurrence after Definitive Treatment of HPV Associated Oropharyngeal Cancers Open

Christopher W. Fleming, M.C. Ward, N.M. Woody, Nikhil Joshi, J.F. Greskovich , et al. · 2019

A management dilemma: adjuvant radiotherapy after gross total resection of atypical meningioma Open

Christopher W. Fleming, Shireen Parsai, John H. Suh · 2019

A management dilemma: adjuvant radiotherapy after gross total resection of atypical meningioma Open

Christopher W. Fleming, Shireen Parsai, John H. Suh · 2019

Weber et al . recently published initial results of a prospective phase II trial of patients with grade II and III meningiomas treated with adjuvant radiotherapy (RT) after subtotal or gross total resection (GTR) (1). This initial publica…

Assessment of Cardiac Dosimetry and Additional Cardiac Risk Factors in Patients Undergoing Modern Breast Cancer Radiation Therapy Open

Christopher W. Fleming, Girish Kunapareddy, Naichang Yu, Rahul D. Tendulkar, Sheen Cherian , et al. · 2018

Current controversies in prostate brachytherapy for prostate cancer Open

Ibrahim Abu‐Gheida, Christopher W. Fleming, Paul Ramia, Omar Y. Mian, Rahul D. Tendulkar , et al. · 2017

Palliative efficacy and local control of conventional radiotherapy for lung metastases Open

Christopher W. Fleming, Andreas Rimner, Amanda Foster, Kaitlin M. Woo, Zhigang Zhang , et al. · 2017

CFRT effectively alleviates a variety of symptoms in lung metastases, supporting its continued use in palliation of metastatic disease. However, subsequent local progression and symptom relapse are common with CFRT. As SBRT is associated w…

Outcomes of IVC stenting with Gianturco-Z stents in non-thrombotic IVC stenosis: a 11-year experience Open

V. K. Iyer, Michael A. McKusick, J. Friese, Haraldur Bjarnason, Andrew H. Stockland , et al. · 2016

High- and low-dose-rate intraoperative radiotherapy for thoracic malignancies resected with close or positive margins Open

Christopher W. Fleming, Andreas Rimner, Gil’ad N. Cohen, Kaitlin M. Woo, Zhigang Zhang , et al. · 2016

Effectiveness of Conventionally Fractionated Radiation Therapy for Lung Metastases Compared With SBRT Open

Christopher W. Fleming, Andreas Rimner, A. Foster, Kaitlin M. Woo, Z. Zhang , et al. · 2015

Christopher W. Fleming YOU? Author Swipe